These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 26811922)
21. Novel agents in development for pediatric sarcomas. Hughes DP Curr Opin Oncol; 2009 Jul; 21(4):332-7. PubMed ID: 19444103 [TBL] [Abstract][Full Text] [Related]
22. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect? Allen D; Rixson L Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815 [TBL] [Abstract][Full Text] [Related]
23. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma. Puls F; Niblett A; Marland G; Gaston CL; Douis H; Mangham DC; Sumathi VP; Kindblom LG Am J Surg Pathol; 2014 Oct; 38(10):1307-18. PubMed ID: 24805859 [TBL] [Abstract][Full Text] [Related]
24. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143 [TBL] [Abstract][Full Text] [Related]
25. Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside. Olmos D; Tan DS; Jones RL; Judson IR Cancer J; 2010; 16(3):183-94. PubMed ID: 20526094 [TBL] [Abstract][Full Text] [Related]
26. Procholecystokinin as marker of human Ewing sarcomas. Reubi JC; Koefoed P; Hansen Tv; Stauffer E; Rauch D; Nielsen FC; Rehfeld JF Clin Cancer Res; 2004 Aug; 10(16):5523-30. PubMed ID: 15328192 [TBL] [Abstract][Full Text] [Related]
27. [Ewing/PNET sarcoma family of tumors: towards a new paradigm?]. Renard C; Ranchère-Vince D Ann Pathol; 2015 Jan; 35(1):86-97. PubMed ID: 25534668 [TBL] [Abstract][Full Text] [Related]
28. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival. Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602 [TBL] [Abstract][Full Text] [Related]
29. Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas. de Souza RR; Oliveira ID; del Giúdice Paniago M; Yaoita FH; Caran EM; Macedo CR; Petrilli AS; Abib Sde C; de Seixas Alves MT; de Toledo SR Growth Horm IGF Res; 2014 Aug; 24(4):130-6. PubMed ID: 24846856 [TBL] [Abstract][Full Text] [Related]
30. The insulin-like growth factor system and sarcomas. Rikhof B; de Jong S; Suurmeijer AJ; Meijer C; van der Graaf WT J Pathol; 2009 Mar; 217(4):469-82. PubMed ID: 19148905 [TBL] [Abstract][Full Text] [Related]
31. Opportunities for improving the therapeutic ratio for patients with sarcoma. Wunder JS; Nielsen TO; Maki RG; O'Sullivan B; Alman BA Lancet Oncol; 2007 Jun; 8(6):513-24. PubMed ID: 17540303 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022 [TBL] [Abstract][Full Text] [Related]
33. Translating gene expression into clinical care: sarcomas as a paradigm. Nielsen TO; West RB J Clin Oncol; 2010 Apr; 28(10):1796-805. PubMed ID: 20194847 [TBL] [Abstract][Full Text] [Related]